(Q84655745)

PubMed ID

20683849

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20683849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

1 reference

Marc De Hert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Mauro Mauri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Ken Shaw

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Tilman Wetterling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Adam Doble

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Agnès Giudicelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

Bruno Falissard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

publication date

1 December 2010

1 reference

PubMed ID

20683849

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20683849%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Methods in Psychiatric Research

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

page(s)

195-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

13 May 2020

cites work

1 reference

12 December 2020

Schizophrenia and comorbid metabolic disorders.

1 reference

12 December 2020

Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study.

1 reference

12 December 2020

Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia

1 reference

12 December 2020

Schizophrenic patients: physical health and access to somatic care.

1 reference

12 December 2020

Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.

1 reference

12 December 2020

Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs

1 reference

12 December 2020

Pharmacological treatment of ambulatory schizophrenic patients in Belgium

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

1 reference

12 December 2020

Causes of the excess mortality of schizophrenia

1 reference

12 December 2020

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

1 reference

12 December 2020

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

12 December 2020

Diabetes mellitus in schizophrenic patients

1 reference

12 December 2020

Metabolic side effects of antipsychotic medication

1 reference

12 December 2020

Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States

1 reference

12 December 2020

Effects of family history and place and season of birth on the risk of schizophrenia

1 reference

12 December 2020

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

12 December 2020

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Patterns of prescription of four major antipsychotics: a retrospective study based on medical records of psychiatric inpatients

1 reference

12 December 2020

Abnormal glucose metabolism in patients treated with antipsychotics

1 reference

12 December 2020

Balancing efficacy and safety in treatment with antipsychotics.

1 reference

12 December 2020

Metabolic syndrome in people with schizophrenia: a review.

1 reference

12 December 2020

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis

1 reference

12 December 2020

Prevalence and correlates of diabetes in national schizophrenia samples.

1 reference

12 December 2020

Identifiers

DOI

10.1002/MPR.322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878539&resulttype=core&format=json

13 May 2020

1 reference